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Objectives This study was designed to review outcomes of pediatric isolated hypertrophic cardiomyopathy (HCM) managed
uniformly at a single institution and assess whether reported adult risk factors for sudden death are predictive in
pediatric HCM.
Background Cardiac death in HCM occurs suddenly (SCD) or may be nonsudden (non-SCD). Little data exists on non-SCD in
children. Risk factors for SCD in adult HCM are characterized and consensus management strategies detailed.
Their application to children is uncertain and treatment strategies vary.
Methods A retrospective cohort study of children with HCM was performed. Primary end points were cardiac death and
transplantation. Frequency and outcomes of known adult risk factors were assessed. Outcomes analysis was
performed using Kaplan-Meier curves and Cox regression analysis.
Results Ninety-six patients were included. The average age at diagnosis was 10.6  5.4 years, and mean follow-up was
6.4  5.2 years. Primary end points occurred in 11 patients over the 20-year follow-up (11%), 4 underwent car-
diac transplant and 7 died (3 suddenly). Extreme left ventricular hypertrophy (z-score: 6) and an abnormal
blood pressure response to exercise were predictive of non-SCD (p  0.02 and p  0.03, respectively). Kaplan-
Meier survival analysis predicts an 82% survival over a 20-year period.
Conclusions In children with isolated HCM managed primarily with exercise restriction and medication, cardiac death oc-
curred infrequently. Non-SCD or transplant was at least as common as SCD. Extreme left ventricular hypertrophy
and blunted blood pressure response to exercise were associated with an increased risk of non-SCD. (J Am
Coll Cardiol 2009;54:250–4) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.03.051d
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Jatients with hypertrophic cardiomyopathy (HCM) are at
isk of death, in the form of sudden cardiac death (SCD) or
rogressive heart failure (non-SCD). Previous studies have
eported that children with HCM have up to a 6% annual
ortality rate (1), although more recent data suggest the
ortality rate is closer to 1% (2,3).
Risk factors for SCD have been identified in large cohorts
f adult patients with HCM (4). Although several studies
ave attempted to risk-stratify children with HCM by
dentifying clinical and laboratory risk factors (3–8), most
ave not been validated. Even less data exist as to risk
actors for the development of end-stage systolic and/or
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009, accepted March 24, 2009.iastolic heart failure in isolated pediatric HCM. Once
ystolic dysfunction is noted, progression to end-stage heart
ailure and death occurs rapidly (9). As limited data are
vailable to identify pediatric patients with HCM at risk for
ardiac death, current treatment strategies are often based
n reported risk factors for SCD in adults. As a result, no
onsensus on the management of pediatric patients exists.
The purpose of this study was to review the clinical
haracteristics and outcomes of our pediatric population
ith isolated HCM who have been managed in a standard
anner and to determine whether reported adult risk factors
or SCD are predictive of outcome in these affected chil-
ren. In addition, we assessed progression to death and
ransplant to determine if any other risk factors for cardiac
eath could be identified.
ethods
tudy patients. A retrospective review of patients between
anuary 1, 1985, and November 1, 2006, with the diagnosis
f HCM was performed through our institutional database,
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July 14, 2009:250–4 Pediatric HCMncluding patients enrolled from our institution in the National
nstitutes of Health–supported PCMR (Pediatric Cardiomy-
pathy Registry) database (2). Criteria for inclusion in the
tudy were age 18 years at the time of diagnosis and
chocardiographic evidence of either concentric left ventricular
ypertrophy or asymmetric septal hypertrophy (defined as a
iastolic septal thickness or left ventricular diastolic wall thick-
ess z-score2) with no other cause. This study was approved
y the Baylor College of Medicine institutional review board.
ndividual consent was waived.
chocardiography. Two-dimensional, Doppler, and M-mode
chocardiography was performed at rest using standard methods.
eft ventricular outflow tract obstruction was defined as a peak
esting gradient16 mm Hg (peak velocity2 m/s). All studies
ere read by a pediatric cardiologist.
ata collection. Demographic information and the re-
orted adult risk factors for sudden death (4), including
xtreme left ventricular hypertrophy, abnormal blood pres-
ure response to exercise, history of prior cardiac arrest or
ustained ventricular tachycardia, documented nonsustained
entricular tachycardia, non-neurocardiogenic syncope, and
family history of HCM with associated sudden death were
ollected. In addition, left ventricular posterior wall and
eptal echocardiographic measurements, degree of left ventric-
lar outflow tract obstruction, exercise stress testing results,
Figure 1 Texas Children’s Hospital Management Algorithm for
Schematic approach to treatment of pediatric hypertrophic cardiomyopathy (HCM).
cardioverter-defibrillator; LVOTO  left ventricular outflow tract obstruction; PHT olter results, clinical symptoms,
nd treatment strategies, including
edications prescribed, pacemaker
r implantable cardioverter-defi-
rillator (ICD) placement, septal
yectomy, and cardiac transplan-
ation were also collected.
xercise testing. Exercise testing
as performed on a Marquette
ediatric treadmill (Marquette
lectronics, Milwaukee, Wiscon-
in), using a standard or modified
ruce protocol. Blood pressure measurements were recorded with
manual sphygmomanometer in the upper extremities during
esting. An abnormal blood pressure response to exercise was
efined as either a hypotensive response or a minimal increase in
he systolic blood pressure to increased workload compared with
aseline (20 mm Hg). Continuous electrocardiograms were
ecorded in all cases. Peak oxygen consumption was measured
hen possible.
anagement algorithm. Patients diagnosed with HCM
ere evaluated in the Cardiomyopathy Clinic. The man-
gement strategy is outlined in Figure 1. Some patients had
ultiple clinical characteristics that fell into more than 1
ategory in the management algorithm.
Abbreviations
and Acronyms
HCM  hypertrophic
cardiomyopathy
ICD  implantable
cardioverter-defibrillator
RSCD  resuscitated
sudden cardiac death
SCD  sudden cardiac
death
implantable
nary hypertension; SCD  sudden cardiac death.HCM
ICD 
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Pediatric HCM July 14, 2009:250–4tatistics. Death and cardiac transplantation were the primary
nd points. Statistical analysis was performed using SPSS for
indows version 16.0 (SPSS, Inc., Chicago, Illinois). Clinical
ariables were converted into groups and univariate analysis
sing the log-rank test was performed. Kaplan-Meier survival
urves were generated. Individual z-score measurements were
un in Kaplan-Meier survival analysis to determine a statisti-
ally significant z-score. Cox regression analysis was used to
erform univariate analysis. Baseline data were reported as a
ean  2 SD, or a median with an interquartile range.
tatistical significance was taken as p  0.05. No adjustments
ere made for a type I error.
atient CharacteristicsTable 1 Patient Characteristics
Demographic data, n (%)
Female 30 (31)
Caucasian 51 (53)
Hispanic 22 (23)
African American 17 (18)
Age at diagnosis
Cohort mean, yrs,  2 SD 10.6 5.4
Cohort median, yrs (IQR) 12.2 (7.8–14.8)
Age 1 yr, n (%) 10 (10)
Age 1 and 5 yrs, n (%) 8 (8)
Age 5 and 10 yrs, n (%) 19 (20)
Age 10 and 18 yrs, n (%) 59 (62)
Family history, n (%)
HCM 41 (43)
HCM-related sudden death 16 (17)
Presenting sign/symptom, n (%)
Murmur 43 (45)
Family history of HCM 18 (19)
Syncope/near-syncope 9 (9)
Chest pain 7 (7)
Dyspnea on exertion 4 (4)
Resuscitated sudden death 4 (4)
Palpitations 1 (1)
Heart failure 1 (1)
Follow-up, yrs
Mean  2 SD 6.4 5.2
Median (IQR) 5 (1 month to 24 yrs)
Death/cardiac transplant, n (%) 11 (11)
Echocardiographic data
Left ventricular morphology, n (%)
Asymmetric septal hypertrophy 68 (71)
Concentric left ventricular hypertrophy 28 (29)
Septal wall z-score in diastole
Mean  2 SD 4.2 2.3
Median (IQR) 4.3 (2.5–5.9)
Posterior wall z-score in diastole
Mean  2 SD 2.2 2.6
Median (IQR) 2.2 (0.5–3.7)
Fractional shortening (n  90)*
Mean  2 SD 46 8.8
Median (IQR) 45 (40–51)a
Quantitative echocardiographic functional analysis not available in all patients.
HCM  hypertrophic cardiomyopathy; IQR  interquartile range.esults
total of 426 patients were diagnosed with hypertrophic
ardiomyopathy between January 1, 1985, and November 1,
006. Ninety-six patients met inclusion criteria for isolated
CM. Clinical characteristics of the patient population are
isted in Table 1. Sixteen patients had a hemodynamic
ssessment in the cardiac catheterization laboratory due to
oninvasive assessments suggesting restrictive physiology or
ulmonary hypertension. Eight of these patients had pul-
onary hypertension (average pulmonary artery mean pres-
ure: 34.1  8.4 mm Hg), all of whom had an elevated
nd-diastolic ventricular pressure consistent with restrictive
hysiology (average: 23  7.3 mm Hg). Three patients had
n elevated end-diastolic ventricular pressure (average end-
iastolic ventricular pressure: 21.3  6.1 mm Hg) without
ulmonary hypertension.
ymptoms. One patient presented with symptomatic heart
ailure due to systolic dysfunction. The reason for the
iagnostic echocardiogram in the other patients is listed in
able 1. The presenting symptom was not documented in the
edical record in 9 (9%) patients. Twenty-seven patients
28%) remained asymptomatic throughout follow-up. The
emaining 69 patients complained of chest pain, fatigue,
yspnea on exertion, palpitations, or a combination of these
uring follow-up. No single symptom or constellation of
ymptoms was a risk factor for cardiac death.
dult risk factors for SCD. The frequency of reported
dult risk factors for SCD is summarized in Table 2. No
ingle or multiple risk factors were predictive of SCD.
owever, a left ventricular wall thickness z-score6 and an
bnormal response to exercise were predictive of non-SCD.
rrhythmias. Seventeen patients had arrhythmias. Five
hildren had atrial tachyarrhythmias and 12 had ventricular
achyarrhythmias. The presence of any arrhythmias, includ-
ng nonsustained ventricular tachycardia on Holter monitor
as not significant for cardiac death.
esuscitated sudden cardiac death (RSCD). Of the 7
atients with an RSCD event, the average age at diagnosis of
CM was 10.3  4.9 years. The rhythm at the time of the
revalence of Adult Risk Factors of Sudden DeathTable 2 Prevalence of Adult Risk Factors of Sudden Death
Risk Factor
(Overall % of Patients)
Survivor
(n  85)
Death/Transplant
(n  11) p Value*
Syncope (18%) 14 3 0.57
Family history of premature
HCM-related death (22%)
20 1 0.35
Nonsustained VT (10%) 9 1 0.76
Prior cardiac arrest (6%) 6 1 0.92
Extreme LVH (z-score 6) (24%) 17 6 0.04
Left ventricular outflow tract
obstruction (40%)
35 3 0.35
Inappropriate BP response to
exercise (20%)†
16 3 0.03
Log-rank test; †58% of total patients underwent exercise testing.
BP  blood pressure; HCM  hypertrophic cardiomyopathy; LVH  left ventricular hypertrophy;
T  ventricular tachycardia.rrest was documented in 4 patients, 2 of whom had ventric-
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July 14, 2009:250–4 Pediatric HCMlar tachycardia and 1 had ventricular fibrillation. One patient
ith an ICD discharge had ventricular tachycardia. This was
he presenting symptom in 4 patients. The 3 patients with a
rior diagnosis of HCM were engaged in restricted physical
ctivity at the time of the arrest. The average septal diastolic
all thickness z-score of this group was 4.9  3.8 and the
verage posterior wall thickness z-score was 2.19  1.5.
chocardiographic analysis. The echocardiographic char-
cteristics of the patient population are summarized in Table 1.
wenty-three patients (27%) had severe hypertrophy with a
iastolic left ventricular posterior wall or diastolic septal wall
hickness z-score6. This included 2 patients who underwent
eart transplantation and 4 who died. A left ventricular
iastolic wall thickness z-score 6 predicted cardiac
eath (p  0.02) (Fig. 2A). The calculated hazard ratio of
ardiac death was 3.8 (95% confidence interval: 1.1 to 12.5).
wo patients who died had qualitatively severely depressed left
entricular systolic function. One additional patient had de-
ressed systolic function before transplantation. The presence,
egree, or absence of left ventricular outflow tract obstruction
id not predict cardiac death.
xercise testing. Fifty-six patients had at least 1 exercise
readmill test. Nineteen (34%) had an abnormal blood pressure
esponse to exercise. Of those undergoing exercise testing, 48
86%) were on beta-blockers and 5 (9%) were on calcium-channel
locker therapy, comprising 95% of those tested. Despite these
edications, 37 (66%) had a normal blood pressure response to
xercise. An abnormal blood pressure response to exercise was a
isk factor for cardiac death (p 0.03) (Fig. 2B). The calculated
azard ratio for cardiac death if there was an abnormal blood
ressure response to exercise was 9.6 (95% confidence interval: 1.0
o 93.7).
CDs. Seventeen patients received ICDs (Fig. 1). The mean
ollow-up time after implantation was 3.6  2.1 years. One
atient, who had an ICD placed for a history of ventricular
Figure 2 Risk Factors for Cardiac Death
Kaplan-Meier survival analysis for left ventricular wall thickness (A) and blood presachycardia and syncope, had 2 appropriate discharges for
entricular tachycardia and 2 inappropriate discharges for atrial
achycardia/fibrillation. This patient was not included in the
nd point analysis as this patient was conscious and this was
onsidered the same as an RSCD event. Two other patients
nderwent cardiac transplantation after ICD placement due to
ersistent heart failure symptoms.
utcomes. Over the 21-year period, there were 11 cardiac
eaths, which consisted of 7 deaths and 4 cardiac transplan-
ations. Of the patient deaths, 3 had sudden cardiac death
nd 3 had non-SCD (2 from systolic heart failure, 1 from a
assive stroke). One cause of death was unknown. Of the
ransplanted patients, 3 (75%) had elevated end-diastolic
ressures and 2 had pulmonary hypertension measured by
ardiac catheterization. All had intractable heart failure symp-
oms, most commonly chest pain, fatigue, and dyspnea on
xertion. One patient had systolic dysfunction at the time of
ransplantation. Kaplan-Meier survival analysis shows an 82%
urvival for the entire group at 21 years (Fig. 3).
iscussion
redicting which patients with HCM are at greatest risk of
udden cardiac death has been the major focus of investi-
ation in adults and children. Risk factors in adult studies
re well described. Studies have been inconsistent in chil-
ren, which may reflect the varying etiologies of HCM
2,3,5,7,8), as well as the low incidence of cardiac death (2),
lso noted in this study. Prior studies have documented the
mportance of non-SCD in infants 1 year of age (2).
owever, in older children, other modes of death are not well
ocumented. In this study, non-SCD was more common than
CD in children. Therefore, although none of the previously
dentified adult risk factors predicted SCD in our pediatric
ohort, the identification of risk factors for non-SCD is at least
s important in children as identifying risk factors for SCD.
esponse to exercise (B).sure r
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Pediatric HCM July 14, 2009:250–4One risk factor was extreme left ventricular hypertrophy,
hich is defined in adult studies as an absolute left ventric-
lar wall thickness of 30 mm (4). Absolute values in children
re not as useful due to changing body surface area. This
tudy is the first to show a significant association between
eft ventricular wall thickness indexed to body surface area,
efined as a z-score 6, and premature death or transplan-
ation in children with isolated HCM.
The second risk factor predictive of cardiac death in
hildren was an abnormal blood pressure response to exer-
ise. Although the majority of children were on a potentially
lood pressure-lowering agent, 66% still maintained a nor-
al blood pressure response. Children with a blunted blood
ressure response to exercise or a hypotensive response to
xercise had a higher incidence of cardiac death.
Although both of these risk factors were predictive of
ardiac death, neither was associated with SCD. This may
e due to the small number of sudden deaths in our
opulation, but it may also be due to the fact that SCD or
SCD is often a presenting symptom in children. In the 7
atients with RSCD, the event was the presenting symptom
or 4. Three patients had an RSCD event after the diagnosis
f HCM was made. All of these patients were noncompli-
nt, engaging in some form of physical activity at the time
f cardiac arrest. The low incidence of SCD seen in this
tudy is similar to that recently reported in the PCMR (2).
he reason for the lower incidence of sudden death in the
ulticenter PCMR cohort is unknown, because manage-
ent approaches and patient compliance could not be
ddressed. In our study, the low incidence of SCD after
iagnosis may be, in part, secondary to the management
trategy of exercise restriction and beta-blockade for virtu-
lly all patients, starting at the time of diagnosis, with
urther treatment based on symptoms and the presence of
Figure 3 Overall Survival
Kaplan-Meier survival analysis for the cumulative survival over the study period.otential risk factors for sudden cardiac death. ttudy limitations. This study is a retrospective survival
nalysis and has limitations intrinsic to such an analysis.
here were a low number of cardiac deaths, and therefore
he study may not be powered to detect all risk factors. In
ddition, the number of patients who underwent catheter-
zation was not enough for statistical analysis. The number
f end points was also small and limited valid multivariate
nalysis. Controlled exercise testing is not possible in young
hildren and infants, and a blunted blood pressure response
o exercise can be normal in pre-pubescent children, making
nterpretation of such data in these patients difficult.
onclusions
atients managed with our treatment algorithm demon-
trated 80% survival over 20 years of follow-up. Cardiac
eath was at least as likely to be from non-SCD as SCD.
herefore, the ability to predict non-SCD is as important as
he ability to predict SCD. A left ventricular wall thickness
-score 6 and an abnormal blood pressure response to
xercise were found to be risk factors for non-SCD and
herefore warrant close follow-up and further study in a
arge multicenter cohort.
eprint requests and correspondence: Dr. Susan W. Denfield,
illie Frank Abercrombie Section of Pediatric Cardiology, Texas
hildren’s Hospital, 6621 Fannin MC 19345-C, Houston, Texas
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